Clinical trial

Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in…

NCT00366275 · Fondazione IRCCS Policlinico San Matteo di Pavia, Other · Completed

Key facts

NCT number NCT00366275
Title Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Relapsed or Refractory Follicular Lymphoma
Official title Phase II of Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Patients With Relapsed or Refractory Follicular Lymphoma
Lead sponsor Fondazione IRCCS Policlinico San Matteo di Pavia, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Follicular Lymphoma
Intervention type Procedure
Interventions Immunochemotherapy, in vivo purging and autrotransplant
Enrollment 64
Start date Jan 1, 2002
Primary completion Jan 1, 2007
Completion Sep 1, 2007
First posted Aug 21, 2006
Last update posted Oct 31, 2012
Countries Italy

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies